Selected research
Market Structure
Global Cancer Imaging Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cancer Imaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cancer Imaging Software include Imaris, Varian, DOSIsoft, Certis Oncology, MIM Software Inc., Arterys, SIEMENS, Brainomix and Oncology Systems Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cancer Imaging Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cancer Imaging Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cancer Imaging Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cancer Imaging Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Cancer Imaging Software Segment by Company
Imaris
Varian
DOSIsoft
Certis Oncology
MIM Software Inc.
Arterys
SIEMENS
Brainomix
Oncology Systems Limited
Mirada
GE HealthCare
Mint Medical
Cancer Imaging Software Segment by Type
CT
MRI
MRA
Others
Cancer Imaging Software Segment by Application
Clinical Routine
Clinical Trials
Cancer Imaging Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Imaging Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cancer Imaging Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cancer Imaging Software industry.
Chapter 3: Detailed analysis of Cancer Imaging Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Imaging Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CT
- MRI
- MRA
- Others
Applications
- Clinical Routine
- Clinical Trials
Companies covered
- Imaris
- Varian
- DOSIsoft
- Certis Oncology
- MIM Software Inc.
- Arterys
- SIEMENS
- Brainomix
- Oncology Systems Limited
- Mirada
- GE HealthCare
- Mint Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cancer Imaging Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 CT
- 1.2.3 MRI
- 1.2.4 MRA
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Cancer Imaging Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinical Routine
- 1.3.3 Clinical Trials
- 1.4 Global Market Growth Prospects
- 1.5 Global Cancer Imaging Software Growth Trends by Region
- 1.5.1 Global Cancer Imaging Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cancer Imaging Software Market Size by Region (2021-2026)
- 1.5.3 Cancer Imaging Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cancer Imaging Software Market Dynamics
- 2.1 Cancer Imaging Software Industry Trends
- 2.2 Cancer Imaging Software Industry Drivers
- 2.3 Cancer Imaging Software Industry Opportunities and Challenges
- 2.4 Cancer Imaging Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cancer Imaging Software Revenue by Company (2021-2026)
- 3.2 Global Cancer Imaging Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cancer Imaging Software Key Company Head office and Area Served
- 3.4 Global Cancer Imaging Software Company, Product Type & Application
- 3.5 Global Cancer Imaging Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cancer Imaging Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cancer Imaging Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Cancer Imaging Software Tier 1, Tier 2, and Tier 3
4 Cancer Imaging Software Market by Type
- 4.1 Global Cancer Imaging Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cancer Imaging Software Market Size by Type (2021-2032)
- 4.3 Global Cancer Imaging Software Market Size Share by Type (2021-2032)
5 Cancer Imaging Software Market by Application
- 5.1 Global Cancer Imaging Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cancer Imaging Software Market Size by Application (2021-2032)
- 5.3 Global Cancer Imaging Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Imaris
- 6.1.1 Imaris Company Information
- 6.1.2 Imaris Business Overview
- 6.1.3 Imaris Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Imaris Cancer Imaging Software Product Portfolio
- 6.1.5 Imaris Recent Developments
- 6.2 Varian
- 6.2.1 Varian Company Information
- 6.2.2 Varian Business Overview
- 6.2.3 Varian Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Varian Cancer Imaging Software Product Portfolio
- 6.2.5 Varian Recent Developments
- 6.3 DOSIsoft
- 6.3.1 DOSIsoft Company Information
- 6.3.2 DOSIsoft Business Overview
- 6.3.3 DOSIsoft Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 DOSIsoft Cancer Imaging Software Product Portfolio
- 6.3.5 DOSIsoft Recent Developments
- 6.4 Certis Oncology
- 6.4.1 Certis Oncology Company Information
- 6.4.2 Certis Oncology Business Overview
- 6.4.3 Certis Oncology Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Certis Oncology Cancer Imaging Software Product Portfolio
- 6.4.5 Certis Oncology Recent Developments
- 6.5 MIM Software Inc.
- 6.5.1 MIM Software Inc. Company Information
- 6.5.2 MIM Software Inc. Business Overview
- 6.5.3 MIM Software Inc. Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 MIM Software Inc. Cancer Imaging Software Product Portfolio
- 6.5.5 MIM Software Inc. Recent Developments
- 6.6 Arterys
- 6.6.1 Arterys Company Information
- 6.6.2 Arterys Business Overview
- 6.6.3 Arterys Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Arterys Cancer Imaging Software Product Portfolio
- 6.6.5 Arterys Recent Developments
- 6.7 SIEMENS
- 6.7.1 SIEMENS Company Information
- 6.7.2 SIEMENS Business Overview
- 6.7.3 SIEMENS Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SIEMENS Cancer Imaging Software Product Portfolio
- 6.7.5 SIEMENS Recent Developments
- 6.8 Brainomix
- 6.8.1 Brainomix Company Information
- 6.8.2 Brainomix Business Overview
- 6.8.3 Brainomix Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Brainomix Cancer Imaging Software Product Portfolio
- 6.8.5 Brainomix Recent Developments
- 6.9 Oncology Systems Limited
- 6.9.1 Oncology Systems Limited Company Information
- 6.9.2 Oncology Systems Limited Business Overview
- 6.9.3 Oncology Systems Limited Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Oncology Systems Limited Cancer Imaging Software Product Portfolio
- 6.9.5 Oncology Systems Limited Recent Developments
- 6.10 Mirada
- 6.10.1 Mirada Company Information
- 6.10.2 Mirada Business Overview
- 6.10.3 Mirada Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Mirada Cancer Imaging Software Product Portfolio
- 6.10.5 Mirada Recent Developments
- 6.11 GE HealthCare
- 6.11.1 GE HealthCare Company Information
- 6.11.2 GE HealthCare Business Overview
- 6.11.3 GE HealthCare Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 GE HealthCare Cancer Imaging Software Product Portfolio
- 6.11.5 GE HealthCare Recent Developments
- 6.12 Mint Medical
- 6.12.1 Mint Medical Company Information
- 6.12.2 Mint Medical Business Overview
- 6.12.3 Mint Medical Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Mint Medical Cancer Imaging Software Product Portfolio
- 6.12.5 Mint Medical Recent Developments
7 North America
- 7.1 North America Cancer Imaging Software Market Size (2021-2032)
- 7.2 North America Cancer Imaging Software Market Size by Type
- 7.2.1 North America Cancer Imaging Software Market Size by Type (2021-2026)
- 7.2.2 North America Cancer Imaging Software Market Size by Type (2027-2032)
- 7.2.3 North America Cancer Imaging Software Market Share by Type (2021-2032)
- 7.3 North America Cancer Imaging Software Market Size by Application
- 7.3.1 North America Cancer Imaging Software Market Size by Application (2021-2026)
- 7.3.2 North America Cancer Imaging Software Market Size by Application (2027-2032)
- 7.3.3 North America Cancer Imaging Software Market Share by Application (2021-2032)
- 7.4 North America Cancer Imaging Software Market Size by Country
- 7.4.1 North America Cancer Imaging Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cancer Imaging Software Market Size by Country (2021-2026)
- 7.4.3 North America Cancer Imaging Software Market Size by Country (2027-2032)
- 7.4.4 North America Cancer Imaging Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cancer Imaging Software Market Size (2021-2032)
- 8.2 Europe Cancer Imaging Software Market Size by Type
- 8.2.1 Europe Cancer Imaging Software Market Size by Type (2021-2026)
- 8.2.2 Europe Cancer Imaging Software Market Size by Type (2027-2032)
- 8.2.3 Europe Cancer Imaging Software Market Share by Type (2021-2032)
- 8.3 Europe Cancer Imaging Software Market Size by Application
- 8.3.1 Europe Cancer Imaging Software Market Size by Application (2021-2026)
- 8.3.2 Europe Cancer Imaging Software Market Size by Application (2027-2032)
- 8.3.3 Europe Cancer Imaging Software Market Share by Application (2021-2032)
- 8.4 Europe Cancer Imaging Software Market Size by Country
- 8.4.1 Europe Cancer Imaging Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cancer Imaging Software Market Size by Country (2021-2026)
- 8.4.3 Europe Cancer Imaging Software Market Size by Country (2027-2032)
- 8.4.4 Europe Cancer Imaging Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cancer Imaging Software Market Size (2021-2032)
- 9.2 China Cancer Imaging Software Market Size by Type
- 9.2.1 China Cancer Imaging Software Market Size by Type (2021-2026)
- 9.2.2 China Cancer Imaging Software Market Size by Type (2027-2032)
- 9.2.3 China Cancer Imaging Software Market Share by Type (2021-2032)
- 9.3 China Cancer Imaging Software Market Size by Application
- 9.3.1 China Cancer Imaging Software Market Size by Application (2021-2026)
- 9.3.2 China Cancer Imaging Software Market Size by Application (2027-2032)
- 9.3.3 China Cancer Imaging Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cancer Imaging Software Market Size (2021-2032)
- 10.2 Asia Cancer Imaging Software Market Size by Type
- 10.2.1 Asia Cancer Imaging Software Market Size by Type (2021-2026)
- 10.2.2 Asia Cancer Imaging Software Market Size by Type (2027-2032)
- 10.2.3 Asia Cancer Imaging Software Market Share by Type (2021-2032)
- 10.3 Asia Cancer Imaging Software Market Size by Application
- 10.3.1 Asia Cancer Imaging Software Market Size by Application (2021-2026)
- 10.3.2 Asia Cancer Imaging Software Market Size by Application (2027-2032)
- 10.3.3 Asia Cancer Imaging Software Market Share by Application (2021-2032)
- 10.4 Asia Cancer Imaging Software Market Size by Country
- 10.4.1 Asia Cancer Imaging Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cancer Imaging Software Market Size by Country (2021-2026)
- 10.4.3 Asia Cancer Imaging Software Market Size by Country (2027-2032)
- 10.4.4 Asia Cancer Imaging Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cancer Imaging Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cancer Imaging Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Cancer Imaging Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cancer Imaging Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cancer Imaging Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cancer Imaging Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Cancer Imaging Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cancer Imaging Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cancer Imaging Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cancer Imaging Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Cancer Imaging Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cancer Imaging Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cancer Imaging Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cancer Imaging Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst